Norbert W. Bischofberger
2010
In 2010, Norbert W. Bischofberger earned a total compensation of $3.8M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $665,039 |
|---|---|
| Option Awards | $1,091,736 |
| Salary | $712,090 |
| Stock Awards | $1,302,000 |
| Other | $5,000 |
| Total | $3,775,865 |
Bischofberger received $1.3M in stock awards, accounting for 34% of the total pay in 2010.
Bischofberger also received $665K in non-equity incentive plan, $1.1M in option awards, $712.1K in salary and $5K in other compensation.
Rankings
In 2010, Norbert W. Bischofberger's compensation ranked 1,490th out of 10,439 executives tracked by ExecPay. In other words, Bischofberger earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,490 out of 10,439 | 86th |
Division Manufacturing | 532 out of 3,838 | 86th |
Major group Chemicals And Allied Products | 106 out of 921 | 89th |
Industry group Drugs | 61 out of 680 | 91st |
Industry Biological Products, Except Diagnostic Substances | 10 out of 142 | 93rd |
Source: SEC filing on March 19, 2013.
Bischofberger's colleagues
We found five more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2010.
2010
John Martin
Gilead Sciences
Chief Executive Officer
2010
John Milligan
Gilead Sciences
Chief Operating Officer
2010
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2010
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2010
Robin Washington
Gilead Sciences